See more here:
Chinook Therapeutics Announces Promotions of Tom Frohlich to Chief Operating Officer and Andrew King, D.V.M, Ph.D., to Chief Scientific Officer

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh